Nuclei Isolation from human cortical tissue for enrichment of endothelial and microglial cells
Benitez, Bruno A. 2024. “Nuclei Isolation from Human Cortical Tissue for Enrichment of Endothelial and Microglial Cells”. Protocols.Io.
Search
Search results
122 results found
Transcriptomic analyses of human brains with Alzheimer’s disease identified dysregulated epilepsy-causing genes
Eteleeb, Abdallah M, Suelen Santos Alves, Stephanie Buss, Mouhsin M Shafi, Daniel Z Press, Norberto Garcia-Cairasco, and Bruno A. Benitez. Submitted. “Transcriptomic Analyses of Human Brains With Alzheimer’s Disease Identified Dysregulated Epilepsy-Causing Genes.”
Lab Alumni
Niko Nikanen Zhaohua Wang Divya Palanisamy Amelia Li
Uncovering the molecular mechanisms behind Alzheimer’s and Parkinson’s disease through multi-omics: an interview with Bruno A. Benitez
Benitez, Bruno A. 2025. “Uncovering the Molecular Mechanisms Behind Alzheimer’s and Parkinson’s Disease through Multi-Omics: An Interview With Bruno A. Benitez”. BioTechniques.
Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.
Benitez, BA, HM Belálcazar, A Anastasía, DT Mamah, CF Zorumski, DH Mascó, DG Herrera, and GA de Erausquin. 2011. “Functional Reduction of SK3-Mediated Currents Precedes AMPA-Receptor-Mediated Excitotoxicity in Dopaminergic Neurons.”. Neuropharmacology.
[Study of genetic variants in the BDNF, COMT, DAT1 and SERT genes in Colombian children with attention deficit disorder].
Ortega-Rojas, Jenny, Carlos E Arboleda-Bustos, Luis Morales, Bruno A Benitez, Diana Beltrán, Álvaro Izquierdo, Humberto Arboleda, and Rafael Vásquez. 2017. “[Study of Genetic Variants in the BDNF, COMT, DAT1 and SERT Genes in Colombian Children With Attention Deficit Disorder].”. Revista Colombiana de Psiquiatria 46 (4): 222-28.
Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer's Disease.
Jin, Sheng Chih, Bruno A Benitez, Yuetiva Deming, and Carlos Cruchaga. 2016. “Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer’s Disease.”. Methods in Molecular Biology (Clifton, N.J.) 1303: 299-314.
Genetic high throughput screening in Retinitis Pigmentosa based on high resolution melting (HRM) analysis.
Anasagasti, Ander, Olatz Barandika, Cristina Irigoyen, Bruno A Benitez, Breanna Cooper, Carlos Cruchaga, Adolfo Lopez de Munain, and Javier Ruiz-Ederra. 2013. “Genetic High Throughput Screening in Retinitis Pigmentosa Based on High Resolution Melting (HRM) Analysis.”. Experimental Eye Research 116: 386-94.
C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease.
Harms, Matthew, Bruno A Benitez, Nigel Cairns, Breanna Cooper, Paul Cooper, Kevin Mayo, David Carrell, et al. 2013. “C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease.”. JAMA Neurology 70 (6): 736-41.